<ref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="B106"><label>106</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hess</surname><given-names>CN</given-names></name><name><surname>Hsia</surname><given-names>J</given-names></name><name><surname>Carroll</surname><given-names>IA</given-names></name><name><surname>Nehler</surname><given-names>MR</given-names></name><name><surname>Ruf</surname><given-names>W</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name><etal/></person-group>. <article-title>Novel tissue factor inhibition for thromboprophylaxis in COVID-19: primary results of the ASPEN-COVID-19 trial</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. (<year>2023</year>) <volume>43</volume>:<page-range>1572&#8211;82</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1161/ATVBAHA.122.318748</pub-id>, PMID: <?supplied-pmid 37381988?><pub-id pub-id-type="pmid">37381988</pub-id>
</mixed-citation></ref>